Literature DB >> 12783864

Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling.

Soichi Tsutsumi1, Takashi Yanagawa, Tatsuo Shimura, Tomoharu Fukumori, Victor Hogan, Hiroyuki Kuwano, Avraham Raz.   

Abstract

Autocrine motility factor (AMF)/phosphoglucose isomerase (PGI; EC 5.3.1.9) is a housekeeping cytosolic enzyme that plays a key role in both glycolysis and gluconeogenesis pathways. AMF/PGI is also a multifunctional protein that displays cytokine properties, eliciting mitogenic, motogenic, and differentiation activities, and has been implicated in tumor progression and metastasis. Because little is known about AMF/PGI-dependent signaling in general and during tumorigenesis in particular, we sought to study its effect on the cell cycle. To elucidate the functional role of PGI, we stably transfected its cDNA into NIH/3T3 and BALB/c 3T3-A31 fibroblasts. Ectopic overexpression of PGI results in the acquisition of a transformed phenotype associated with an acceleration of G1 to S cell cycle transition. These were manifested by up-regulation of cyclin D1 expression and cyclin-dependent kinase activity and down-regulation of the cyclin-dependent kinase inhibitor p27Kip1. The reduced p27Kip1 protein expression level in PGI-overexpressing cells could be restored to control levels by treatment with proteasome inhibitor. PGI-overexpressing cells also exhibited elevated expression of Skp2 involved in p27Kip1 ubiquitination and elevation in the levels of retinoblastoma protein hyperphosphorylation. Thus, we may conclude that the overexpression of AMF/PGI enhances cell proliferation together with up-regulation of cyclin/cyclin-dependent kinase activities and down-regulation of p27Kip1, whereas the induction of 3T3 fibroblast transformation by PGI is regulated by the retinoblastoma protein pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12783864     DOI: 10.1074/jbc.M304537200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis.

Authors:  Yasufumi Niinaka; Kiyoshi Harada; Masahiro Fujimuro; Masamitsu Oda; Arayo Haga; Misa Hosoki; Narikazu Uzawa; Naoya Arai; Satoshi Yamaguchi; Masashi Yamashiro; Avraham Raz
Journal:  Cancer Res       Date:  2010-10-26       Impact factor: 12.701

Review 2.  Chemical genomics: a challenge for de novo drug design.

Authors:  P M Dean
Journal:  Mol Biotechnol       Date:  2007-06-30       Impact factor: 2.695

3.  Monoclonal antibodies against autocrine motility factor suppress gastric cancer.

Authors:  Hahn-Sun Jung; Su In Lee; Seung-Hoon Kang; Jin Sang Wang; Eun Hee Yang; Byungwook Jeon; Jayhyuk Myung; Ji Young Baek; Song-Kyu Park
Journal:  Oncol Lett       Date:  2017-04-13       Impact factor: 2.967

4.  Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells.

Authors:  Caroline Bret; Dirk Hose; Thierry Reme; Anne-Catherine Sprynski; Karène Mahtouk; Jean-François Schved; Philippe Quittet; Jean-François Rossi; Hartmut Goldschmidt; Bernard Klein
Journal:  Br J Haematol       Date:  2009-03-02       Impact factor: 6.998

5.  Autocrine motility factor stimulates the invasiveness of malignant cells as well as up-regulation of matrix metalloproteinase-3 expression via a MAPK pathway.

Authors:  Arayo Haga; Tatsuyoshi Funasaka; Yoshihiro Deyashiki; Avraham Raz
Journal:  FEBS Lett       Date:  2008-05-15       Impact factor: 4.124

6.  Phosphoglucose isomerase/autocrine motility factor promotes melanoma cell migration through ERK activation dependent on autocrine production of interleukin-8.

Authors:  Kenichiro Araki; Tatsuo Shimura; Toshiki Yajima; Soichi Tsutsumi; Hideki Suzuki; Kohji Okada; Tsutomu Kobayashi; Avraham Raz; Hiroyuki Kuwano
Journal:  J Biol Chem       Date:  2009-09-30       Impact factor: 5.157

7.  Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor.

Authors:  Kosei Nakajima; Takashi Yanagawa; Hideomi Watanabe; Kenji Takagishi
Journal:  Oncol Rep       Date:  2012-10-01       Impact factor: 3.906

Review 8.  Chicken or the egg: Warburg effect and mitochondrial dysfunction.

Authors:  Deniz Senyilmaz; Aurelio A Teleman
Journal:  F1000Prime Rep       Date:  2015-04-02

9.  Proteomics reveals multiple routes to the osteogenic phenotype in mesenchymal stem cells.

Authors:  Kristin P Bennett; Charles Bergeron; Evrim Acar; Robert F Klees; Scott L Vandenberg; Bülent Yener; George E Plopper
Journal:  BMC Genomics       Date:  2007-10-19       Impact factor: 3.969

10.  AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma.

Authors:  Yiran Li; Yuanhui Jia; Qi Che; Qian Zhou; Kai Wang; Xiao-Ping Wan
Journal:  Oncotarget       Date:  2015-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.